Shaikh A. Ali
Expertise in
13
conditions

Dr. Shaikh A. Ali

Rheumatology
455 School St, Ste 27, 
Tomball, TX 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
13
conditions
455 School St, Ste 27, 
Tomball, TX 

Overview

Shaikh Ali is a Rheumatologist practicing medicine in Tomball, Texas.

Dr. Ali is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Postmenopausal Osteoporosis.

He is actively involved in clinical research, participating in 8 clinical trials. Dr. Ali is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in TX

Fellowships

Vanderbilt University Medical Center 1995

Hospital Affiliations

Hca Houston Healthcare Tomball

Languages Spoken

English
Hindi
Spanish
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

455 School St, Ste 27, Tomball, TX 77375
Other Locations
17045 Saint Edwards Dr, Ste 110, Houston, TX 77090

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials
Similar Doctors
Expertise in
1
conditions
Dr. Rama R. Palwai
Rheumatology
Expertise in
1
conditions
Dr. Rama R. Palwai
Rheumatology
Referral may be required
Before you request

Montgomery Internal Medicine PLLC

425 Holderrieth Blvd Ste 108, 
Tomball, TX 
 (2.0 miles away)
Languages Spoken:
English, Hindi, Spanish
See accepted insurances
Accepting New Patients

Rama Palwai is a Rheumatologist practicing medicine in Tomball, Texas. Dr. Palwai is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Psoriatic Arthritis. Dr. Palwai is currently accepting new patients.

Expertise in
12
conditions
Dr. Qaiser Rehman
Rheumatology
Expertise in
12
conditions
Dr. Qaiser Rehman
Rheumatology
Referral may be required
17134 N Eldridge Pkwy, Ste A, 
Tomball, TX 
 (4.2 miles away)
832-237-8585
Languages Spoken:
English, Hindi, Punjabi, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Qaiser Rehman is a Rheumatologist practicing medicine in Tomball, Texas. Dr. Rehman is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Ankylosing Spondylitis. Dr. Rehman is currently accepting new patients.

Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

Kelsey Seybold Clinic (Physicians)

22407 Holzwarth Rd, 
Spring, TX 
 (6.5 miles away)
346-674-4000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Matxalen Amezagaurruela is a Rheumatologist practicing medicine in Spring, Texas. Dr. Amezagaurruela is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and MASS Phenotype. Dr. Amezagaurruela is currently accepting new patients.

Expertise in
7
conditions
Dr. Zunaira Ali
Rheumatology
Expertise in
7
conditions
Dr. Zunaira Ali
Rheumatology
Referral may be required
22485 Tomball Pkwy, Ste 2100, 
Houston, TX 
 (5.7 miles away)
281-955-2650
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Zunaira Ali is a Rheumatologist practicing medicine in Houston, Texas. Dr. Ali is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Rheumatoid Vasculitis, Ankylosing Spondylitis, and Axial Spondyloarthritis (AxSpA). Dr. Ali is currently accepting new patients.

Expertise in
1
conditions
Dr. Iqtidar Hanif
Rheumatology
Expertise in
1
conditions
Dr. Iqtidar Hanif
Rheumatology
Referral may be required
Before you request
455 School St, Ste 27, 
Tomball, TX 
 (0.1 miles away)
281-357-0666
Languages Spoken:
English, Spanish, Urdu
See accepted insurances
Accepting New Patients

Iqtidar Hanif is a Rheumatologist practicing medicine in Tomball, Texas. Dr. Hanif is highly rated in 1 condition, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Raynaud Phenomenon. Dr. Hanif is currently accepting new patients.

Expertise in
16
conditions
Dr. Astrud L. Leyva
Rheumatology
Expertise in
16
conditions
Dr. Astrud L. Leyva
Rheumatology
Referral may be required
Before you request

Houston Methodist Rheumatology Associates

13300 Hargrave Rd Ste 300, 
Houston, TX 
 (7.9 miles away)
281-737-7277
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Astrud Leyva is a Rheumatologist practicing medicine in Houston, Texas. Dr. Leyva is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Systemic Sclerosis (SSc). Dr. Leyva is currently accepting new patients.

Frequently Asked Questions about Dr. Shaikh A. Ali

How do I make an appointment with Dr. Shaikh A. Ali?

You can book an appointment with Dr. Shaikh A. Ali by calling their office at 281-357-0666. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shaikh A. Ali a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shaikh A. Ali is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shaikh A. Ali specialize in?

While Dr. Shaikh A. Ali is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Psoriatic Arthritis, and Psoriasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Shaikh A. Ali accept my insurance?

Dr. Shaikh A. Ali accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 281-357-0666 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ali's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile